Karalashvili L, Kakabadze A, Uhryn M, Vyshnevska H, Ediberidze K, Kakabadze Z
Tbilisi State Medical University, Georgia; Lviv National Medical University; The Institute of Stomatology and Maxilo-Facial Surgery National Academy of Medical Sciences of Ukraine, Odessa, Ukraine.
Tbilisi State Medical University, Georgia; Lviv National Medical University.
Georgian Med News. 2018 Sep(282):44-49.
Reconstruction of large size defects of bone is a challenging task. To this date, discussions and controversies on selection of auto-, allo-, xeno- or synthetic grafts continue to take place. Vascularized autologous bone graft is considered as gold standard in reconstruction of large size defects of bone; however an additional surgery is required for obtaining it. Allografts and xenografts possess osteoconductive features, but osteogenesis is less expressed and risk of various infection transmissions is high and may have probability of developing immunological conflict. Main advantages of grafts created from synthetic materials through bioengineering methods are biocompatibility and good bioreabsorption. Despite these features, studies related to the creation of an ideal bone graft continue to take place that should have biomechanical stability, be able to degrade within an appropriate period, exhibit osteoconductive, osteogenic and osteoinductive properties. Nowadays, there is an attempt of creating grafts that contain platelet-rich plasma, growth factors or stem cells for strengthening osteoconduction and osteoinduction of bone grafts. In 2016, we created bioactive bone from decellularized bovine femoral bone and freeze-dried bone marrow stem cell paracrine factors. We hypothesized that freeze-dried BMSC paracrine factors would have ability to strengthen osteoinduction, osteoconduction and osteointegration. Experimental and preliminary clinical investigations indicated that bioactive bone grafts containing freeze-dried BMSC paracrine factors may be used for reconstruction of large size bone defects. Despite acquired positive results, it requires multiple experimental and clinical studies for further improvement of graft.
大尺寸骨缺损的重建是一项具有挑战性的任务。迄今为止,关于自体、异体、异种或合成移植物选择的讨论和争议仍在继续。带血管自体骨移植被认为是大尺寸骨缺损重建的金标准;然而,获取它需要进行额外的手术。同种异体移植物和异种移植物具有骨传导特性,但骨生成表达较少,各种感染传播的风险较高,并且可能有发生免疫冲突的可能性。通过生物工程方法由合成材料制成的移植物的主要优点是生物相容性和良好的生物吸收性。尽管有这些特性,但关于制造一种理想骨移植物的研究仍在继续,这种骨移植物应具有生物力学稳定性,能够在适当的时期内降解,表现出骨传导、骨生成和骨诱导特性。如今,人们尝试制造含有富血小板血浆、生长因子或干细胞的移植物,以增强骨移植物的骨传导和骨诱导作用。2016年,我们从脱细胞牛股骨和冻干骨髓干细胞旁分泌因子中制备了生物活性骨。我们假设冻干的骨髓间充质干细胞旁分泌因子将具有增强骨诱导、骨传导和骨整合的能力。实验和初步临床研究表明,含有冻干骨髓间充质干细胞旁分泌因子的生物活性骨移植物可用于大尺寸骨缺损的重建。尽管取得了积极的结果,但仍需要进行多项实验和临床研究以进一步改进移植物。